Volume 8, Issue 3 October 2014
There have been reports of thrombotic microangiopathy and nephrotic syndrome linked to interferon beta treatment. Be vigilant for early signs or symptoms of these conditions (see below) and treat these conditions promptly if they occur.
From October 2014 Dexamethasone 4 mg/ml injection (Organon Laboratories Limited) will be replaced with a new formulation called Dexamethasone 3.8 mg/ml solution for injection (Aspen Pharma Trading Limited).
To get the very latest drug safety news and drug alerts as soon as they are released, sign up here